Average Co-Inventor Count = 7.86
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (40 from 2,405 patents)
2. Merck Canada Inc. (4 from 40 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
4. Merck & Co., Inc. and Merck Sharp & Dohme Corp. (1 from 1 patent)
42 patents:
1. 12264139 - Aryl sulfonamides as BLT1 antagonists
2. 12152019 - Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors
3. 11981701 - PRMT5 inhibitors
4. 11685761 - Cyclic di-nucleotide compounds as sting agonists
5. 11466047 - Cyclic di-nucleotide compounds as sting agonists
6. 11319283 - Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
7. 11111232 - Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
8. 10793557 - Sting agonist compounds
9. 10766919 - Cyclic di-nucleotide compounds as sting agonists
10. 10759805 - Compounds that are ERK inhibitors
11. 10759825 - Cyclic di-nucleotide compounds as STING agonists
12. 10730849 - Benzo[b]thiophene compounds as STING agonists
13. 10703738 - Benzo[b]thiophene compounds as STING agonists
14. 10414747 - Benzo[b]thiophene compounds as sting agonists
15. 10336733 - Aryl acylsulfonamides as BLT1 antagonists